title: Prevalence, awareness, treatment and control of hypertension in adults with chronic kidney disease in Turkey: results from the CREDIT study.
abstract: BACKGROUND
  In the Chronic REnal Disease in Turkey-CREDIT Study, a large populationbased study on 10,748 adults, the prevalence of chronic kidney disease (CKD) and relationship between CKD and other cardiovascular risk factors had been studied.
  
  
  METHODS
  This report presents the results of CREDIT study on the prevalence, awareness, treatment, and control of hypertension among CKD patients.
  
  
  RESULTS
  The prevalence and awareness of hypertension in CREDIT population was 32.7% and 48.6%, respectively. Of the patients with hypertension, 31.5% were under treatment, and 16.4% had hypertension under control. Prevalence of CKD was 25.3% in patients with hypertension. Among CKD patients (15.7% of the CREDIT study population), 56.3% had hypertension. The prevalence of hypertension was 34.8% at stage 1, 79.8% at stage 3, and 92.3% at stage 5 CKD. Only 13.4% of patients with CKD have optimal blood pressure. Among CKD patients, 61.9% were aware of hypertension, and 44.2% were under treatment. Overall control rate of hypertension in subjects with CKD was 16.3% with the lowest rate at stage 1 (12.3%) and highest rate at stage 4 (40%). The control rate increased to 28.8% for CKD patients under treatment for hypertension.
  
  
  CONCLUSIONS
  As a conclusion, hypertension is highly prevalent in subjects with CKD in Turkey with suboptimal awareness, treatment, and control rates. Appropriate health strategies should be implicated to improve prevention, early diagnosis, and treatment of hypertension, which is one of the leading causes of CKD.
authors: Department of Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkiye. Mail baltun@hacettepe.edu.tr
authors: Bülent
authors: B
authors: Altun
authors: Gültekin
authors: G
authors: Süleymanlar
authors: Cengiz
authors: C
authors: Utaş
authors: Turgay
authors: T
authors: Arınsoy
authors: Kenan
authors: K
authors: Ateş
authors: Tevfik
authors: T
authors: Ecder
authors: Taner
authors: T
authors: Camsarı
authors: Kamil
authors: K
authors: Serdengeçti
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001364:Awareness; D015897:Comorbidity; D005260:Female; D005919:Glomerular Filtration Rate / Q000502:physiology; D006306:Health Surveys; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000453:epidemiology*; D007668:Kidney / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011634:Public Health / Q000193:education*; D051436:Renal Insufficiency, Chronic / Q000453:epidemiology*; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014421:Turkey / Q000453:epidemiology; D055815:Young Adult
chemical_list: D000959:Antihypertensive Agents